Shuichi Suetani blogs a new study published today in The Lancet Psychiatry, which suggests that those patients who might benefit most from evidence-based guidance are the least represented in clinical trials about ADHD medication. Is it time to reconsider the value we place on RCTs when they do not include the vast majority of people who need help?
[read the full story...]Omega-3 supplements for the prevention of psychosis: another trial shows no benefit, so is it time to move on?
David Mongan reports on a recent trial of omega-3 supplementation for the prevention of psychosis in people at ultra-high risk, which finds no evidence of a positive effect. He reflects on these findings and considers what’s next for the field.
[read the full story...]KarXT: an innovative and promising treatment for schizophrenia
Nicola Rizzo Pesci and Andrea Cipriani summarise findings from the EMERGENT-2 trial spotlighting a promising new drug treatment for schizophrenia.
[read the full story...]ACT now for MND: acceptance and commitment therapy can improve quality of life for people with motor neuron disease
Dona Matthews summarises a recent trial which suggests that Acceptance and Commitment Therapy can maintain or improve quality of life for people with early stage motor neuron disease.
[read the full story...]Can self help apps PROMOTE wellbeing or PREVENT illness in young adults?
Kirsten Lawson summarises the ECoWeB PROMOTE and PREVENT trials in relation to self-helps apps for promoting wellbeing and preventing mental ill health among young adults.
[read the full story...]Apps for depression and anxiety: big new meta-analysis supports effectiveness
In their debut blog, Lee Valentine summarises a large-scale updated meta-analysis investigating the effectiveness of mental health apps for depression and anxiety.
[read the full story...]Is my depression the same as your depression? Network analysis finds individual variation in how symptoms aggravate each other over time
Giulia Piazza and Jonathan Roiser explore a recent network analysis and ecological momentary assessment study, which provides clear evidence that the relationships between depressive symptoms vary between individuals with depression who are matched on overall depression severity.
[read the full story...]Predicting antidepressant response using artificial intelligence
Holly Fraser discusses new findings on whether and how we can predict antidepressant response using artificial intelligence.
[read the full story...]Digital self-help for bulimia recovery: encouraging results for waiting list management
In her debut blog, Ana Julia Ferreira summarises a randomised controlled trial investigating the effectiveness of a digital self-help intervention for improving bulimic-spectrum disorder symptomatology while on a treatment waiting list.
[read the full story...]The great unknown? Assessing suicide risk in trials of psychological interventions for depression
Derek de Beurs explores a meta-analysis which finds that randomised controlled trials of psychological interventions for depression rarely report assessments of suicide.
[read the full story...]